ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each

June 11, 1982

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987